Source: Eur Respir J 2016; 47: 769-782
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Samitas Konstantinos, Poulos Nikolaos, Semitekolou Maria, Morianos Ioannis, Tousa Sofia, Economidou Erasmia, Robinson Douglas S., Kariyawasam Harsha H., Zervas Eleftherios, Corrigan Christopher J., Ying Sun, Xanthou Georgina, Gaga Mina. Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes. Eur Respir J 2016; 47: 769-782

Member's Comments

No comment yet.

Related content which might interest you: Activin-A expression is increased in severe asthma and is involved in tissue angiogenesis Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Benralizumab restored expression of key molecules involved in steroid-resistance in patients with severe asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma Source: Eur Respir J 2016; 48: 715-725 Year: 2016 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Fibroblast growth factors induce proliferation of cultured human airway smooth muscle cells: autocrine role in the pathogenesis of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 78s Year: 2001 Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7 Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Adapalene abrogates erlotinib-induced skin disorder by regulating proinflammatory cytokine production from human epidermal cells Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 LSC 2013 abstract - Activin-A is up-regulated in severe asthma and is associated with angiogenesis Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 HIF dependent regulation of S100A4 protein in COPD induced vascular remodelling Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity Source: ERS Lung Science Conference 2021 Year: 2021 IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018 Year: 2019 DJ-1 and its anti-oxidative stress response regulates the expression of sirtuin-1 in COPD epithelial cells Source: International Congress 2017 – Translational studies of lung disease Year: 2017 RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002 Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006